Search Results - "Ohsaka, Akimichi"
-
1
Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms
Published in Blood (10-03-2016)“…Recurrent somatic mutations of calreticulin (CALR) have been identified in patients harboring myeloproliferative neoplasms; however, their role in…”
Get full text
Journal Article -
2
A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib
Published in PloS one (05-03-2019)“…Tyrosine kinase inhibitors (TKIs) targeting the BCR-ABL1 fusion protein, encoded by the Philadelphia chromosome, have drastically improved the outcomes for…”
Get full text
Journal Article -
3
Mutant calreticulin interacts with MPL in the secretion pathway for activation on the cell surface
Published in Leukemia (01-02-2020)“…Studies have shown that mutant calreticulin (CALR) constitutively activates the thrombopoietin (TPO) receptor MPL and thus plays a causal role in the…”
Get full text
Journal Article -
4
Homomultimerization of mutant calreticulin is a prerequisite for MPL binding and activation
Published in Leukemia (01-01-2019)“…Studies have previously shown that mutant calreticulin (CALR), found in a subset of patients with myeloproliferative neoplasms (MPNs), interacts with and…”
Get full text
Journal Article -
5
Automated diagnostic support system with deep learning algorithms for distinction of Philadelphia chromosome-negative myeloproliferative neoplasms using peripheral blood specimen
Published in Scientific reports (09-02-2021)“…Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-negative MPNs) such as polycythemia vera (PV), essential thrombocythemia (ET), and primary…”
Get full text
Journal Article -
6
CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome–negative myeloproliferative neoplasms
Published in Cancer science (01-02-2021)“…Discrimination of Philadelphia‐negative myeloproliferative neoplasms (Ph‐MPNs) from reactive hypercytosis and myelofibrosis requires a constellation of testing…”
Get full text
Journal Article -
7
Clinical impacts of the mutational spectrum in Japanese patients with primary myelofibrosis
Published in International journal of hematology (01-04-2021)“…Patients with primary myelofibrosis (PMF) have a poorer prognosis than those with other subtypes of myeloproliferative neoplasms (MPNs). To investigate the…”
Get full text
Journal Article -
8
Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms
Published in International journal of hematology (01-06-2018)“…The majority of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) harbor JAK2 , CALR , or MPL mutations. We compared clinical…”
Get full text
Journal Article -
9
Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells
Published in The Journal of biological chemistry (17-02-2017)“…Differentiation therapy with all-trans-retinoic acid (ATRA) improves the treatment outcome of acute promyelocytic leukemia (APL); however, the molecular…”
Get full text
Journal Article -
10
Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy
Published in Haematologica (Roma) (01-11-2019)Get full text
Journal Article -
11
The 24-h reporting of Gram stains from positive blood cultures contributes to physician's use of appropriate antimicrobials: Experience at a university hospital
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-06-2022)“…Although recent technological advances for the diagnosis of bloodstream infection (BSI) provide rapid and accurate results, blood culture maintains a key role…”
Get full text
Journal Article -
12
Evaluation of cell count and classification capabilities in body fluids using a fully automated Sysmex XN equipped with high-sensitive Analysis (hsA) mode and DI-60 hematology analyzer system
Published in PloS one (26-04-2018)“…The XN series automated hematology analyzer has been equipped with a body fluid (BF) mode to count and differentiate leukocytes in BF samples including…”
Get full text
Journal Article -
13
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex
Published in BMC microbiology (19-10-2020)“…Nontuberculous mycobacteria (NTM) are ubiquitous organisms and the incidence of NTM infections has been increasing in recent years. Mycobacteroides abscessus…”
Get full text
Journal Article -
14
Threshold for optimal administration of plerixafor in autologous peripheral blood stem cell collections through CD34+ cell monitoring based on the experience from two Japanese university hospitals
Published in Therapeutic apheresis and dialysis (01-10-2021)“…Plerixafor was introduced to Japan in 2017 as a stem cell mobilization enhancement reagent, but the threshold for its use remains unclear. In this study, we…”
Get full text
Journal Article -
15
Novel flowcytometry-based approach of malignant cell detection in body fluids using an automated hematology analyzer
Published in PloS one (09-02-2018)“…Morphological microscopic examinations of nucleated cells in body fluid (BF) samples are performed to screen malignancy. However, the morphological…”
Get full text
Journal Article -
16
Impact of CD34+ pre-counting and plerixafor on autologous peripheral blood stem cell collection in Japanese university hospitals in eight years
Published in Transfusion and apheresis science (01-12-2019)“…Over the past decade, there have been two major advancements in autologous peripheral blood stem cell (PBSC) collection, namely enumeration of CD 34+ cells for…”
Get full text
Journal Article -
17
CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells
Published in Molecular cancer therapeutics (01-01-2008)“…Chronic myelogenous leukemia (CML) is driven by constitutively activated Bcr-Abl tyrosine kinase, which causes the defective adhesion of CML cells to bone…”
Get full text
Journal Article -
18
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells
Published in Cancer research (Chicago, Ill.) (15-01-2007)“…Integrin-linked kinase (ILK) directly interacts with beta integrins and phosphorylates Akt in a phosphatidylinositol 3-kinase (PI3K)-dependent manner. In this…”
Get full text
Journal Article -
19
A survey of nurses to assess transfusion practice at the bedside using an electronic identification system: Experience at a university hospital
Published in Transfusion medicine (Oxford, England) (01-02-2021)“…Objectives The objective of this study was to assess the performance and recognition of transfusion practice at the bedside by nurses in our hospital, where a…”
Get full text
Journal Article -
20
JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasms
Published in Haematologica (Roma) (01-02-2015)Get full text
Journal Article